Dr Praveensingh Hajeri

These researchers are actively researching and developing innovative methods for diagnostics and scientific investigation using Next-Generation Sequencing (NGS) technology, specifically on the Illumina platform. Their NGS applications encompass a wide range of areas, including discovering novel biomarkers, diagnosing viral diseases, investigating cancer mechanisms, and conducting high-throughput screening of recombinant viruses. The group anticipates expanding their applications to include samples from archaeological contexts and museum collections.